Doctor Kazuhisa Kodama
Saiseikai Kumamoto Hospital, Kumamoto (Japan)
A low dose Pimobendan was observed to prolong the period until re-hospitalization for Japanese patients with advanced heart failure, especially in the vulnerable post-discharge period.
Event: Heart Failure 2019
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
ESC 365 is supported by
